<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001903'>Anemia</z:hpo> is an important cause of morbidity in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, principally through increased <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Transfusion status has been seen to be a significant prognostic factor for disease progression and mortality, yet the relationship between <z:hpo ids='HP_0001903'>anemia</z:hpo> levels and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> is not well understood </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: This study aimed to review the published literature on the effect of <z:hpo ids='HP_0001903'>anemia</z:hpo> on cardiovascular outcomes in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A systematic literature review was undertaken to identify studies that investigated the relationship between <z:hpo ids='HP_0001903'>anemia</z:hpo> (as defined by <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels) and cardiovascular outcomes in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> subtypes) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Three studies were identified that explicitly evaluated the relationship between <z:hpo ids='HP_0001903'>anemia</z:hpo> and cardiovascular outcomes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and another study reported the relationship between <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels and survival </plain></SENT>
<SENT sid="5" pm="."><plain>The four studies consistently showed a strong relationship between lower <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels and worse cardiovascular outcomes, including cardiac remodeling, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, <z:e sem="disease" ids="C0018824" disease_type="Disease or Syndrome" abbrv="">heart valve disease</z:e>, and cardiovascular mortality </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> was seen to be an independent predictor of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> outcomes in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, beyond transfusion status and IPSS </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Based upon a relatively small body of evidence, there appears to be a strong and clinically significant association between <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> and mortality in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>While further research is needed, clinicians should seek to actively manage <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients before the point of transfusion dependency is reached </plain></SENT>
</text></document>